Pulmonx (LUNG) Enterprise Value (2020 - 2025)

Pulmonx (LUNG) has reported Enterprise Value for 6 consecutive years, with $22.3 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Enterprise Value fell 86.75% year-over-year to $22.3 million in Q4 2025; TTM through Dec 2025 was $22.3 million, a 86.75% decrease from a year earlier, with the FY2025 full-year figure at $22.3 million, down 86.75% from the prior year.
• Enterprise Value was $22.3 million for Q4 2025 at Pulmonx, up from -$9.7 million in the prior quarter.
• Over five years, Enterprise Value peaked at $1.4 billion in Q1 2021 and troughed at -$9.7 million in Q3 2025.
• A 5-year average of $449.9 million and a median of $274.1 million in 2023 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value soared 113.15% in 2023 and slumped 104.43% in 2025, its largest moves.
• Over 5 years, Enterprise Value stood at $1.0 billion in 2021, then slumped by 82.53% to $175.5 million in 2022, then jumped by 113.15% to $374.0 million in 2023, then plunged by 54.9% to $168.7 million in 2024, then sank by 86.75% to $22.3 million in 2025.
• The last three Enterprise Value figures came in at $22.3 million (Q4 2025), -$9.7 million (Q3 2025), and $21.3 million (Q2 2025), per Business Quant data.